Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 2
1947 2
1952 3
1953 4
1954 3
1956 2
1957 3
1958 5
1959 3
1960 2
1961 3
1962 1
1963 1
1964 4
1965 2
1966 3
1967 2
1968 4
1969 6
1970 1
1971 2
1972 3
1973 4
1974 7
1975 4
1976 2
1977 5
1978 5
1980 5
1981 2
1982 6
1983 10
1984 12
1985 12
1986 19
1987 11
1988 18
1989 13
1990 23
1991 12
1992 14
1993 19
1994 15
1995 23
1996 17
1997 22
1998 32
1999 18
2000 27
2001 30
2002 34
2003 29
2004 19
2005 28
2006 47
2007 36
2008 51
2009 49
2010 35
2011 25
2012 29
2013 21
2014 23
2015 28
2016 26
2017 36
2018 32
2019 34
2020 41
2021 31
2022 34
2023 35
2024 17

Text availability

Article attribute

Article type

Publication date

Search Results

1,104 results

Results by year

Filters applied: . Clear all
Proximity search should include two or more words. Proximity operator ignored :~0
Page 1
ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.
Chey WD, Leontiadis GI, Howden CW, Moss SF. Chey WD, et al. Am J Gastroenterol. 2017 Feb;112(2):212-239. doi: 10.1038/ajg.2016.563. Epub 2017 Jan 10. Am J Gastroenterol. 2017. PMID: 28071659
H. pylori may also have a role in uninvestigated and functional dyspepsia, ulcer risk in patients taking low-dose aspirin or starting therapy with a non-steroidal anti-inflammatory medication, unexplained iron deficiency anemia, and idiopathic thrombocytopenic purpura …
H. pylori may also have a role in uninvestigated and functional dyspepsia, ulcer risk in patients taking low-dose aspirin or starting the …
Diagnosis and treatment of thrombotic microangiopathy.
Thompson GL, Kavanagh D. Thompson GL, et al. Int J Lab Hematol. 2022 Sep;44 Suppl 1(Suppl 1):101-113. doi: 10.1111/ijlh.13954. Int J Lab Hematol. 2022. PMID: 36074708 Free PMC article. Review.
Ground-breaking research into the pathogenesis of TMAs over the past 20 years has driven the successful development of targeted therapeutics revolutionizing patient outcomes. This review outlines the clinical presentations, pathogenesis, diagnostic tests and treatments for …
Ground-breaking research into the pathogenesis of TMAs over the past 20 years has driven the successful development of targeted therapeut …
Diagnosis and management of leukocytoclastic vasculitis.
Fraticelli P, Benfaremo D, Gabrielli A. Fraticelli P, et al. Intern Emerg Med. 2021 Jun;16(4):831-841. doi: 10.1007/s11739-021-02688-x. Epub 2021 Mar 13. Intern Emerg Med. 2021. PMID: 33713282 Free PMC article. Review.
Among systemic diseases, the most frequently associated with LCV are ANCA-associated vasculitides, connective tissue diseases, cryoglobulinemic vasculitis, IgA vasculitis (formerly known as Henoch-Schonlein purpura) and hypocomplementemic urticarial vasculitis (HUV). When …
Among systemic diseases, the most frequently associated with LCV are ANCA-associated vasculitides, connective tissue diseases, cryoglobuline …
European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative.
Ozen S, Marks SD, Brogan P, Groot N, de Graeff N, Avcin T, Bader-Meunier B, Dolezalova P, Feldman BM, Kone-Paut I, Lahdenne P, McCann L, Pilkington C, Ravelli A, van Royen A, Uziel Y, Vastert B, Wulffraat N, Kamphuis S, Beresford MW. Ozen S, et al. Rheumatology (Oxford). 2019 Sep 1;58(9):1607-1616. doi: 10.1093/rheumatology/kez041. Rheumatology (Oxford). 2019. PMID: 30879080
OBJECTIVES: IgA vasculitis (IgAV, formerly known as Henoch-Schonlein purpura) is the most common cause of systemic vasculitis in childhood. ...Treatment recommendations included: the importance of appropriate analgesia and angiotensin-converting enzyme inhibitor use and no …
OBJECTIVES: IgA vasculitis (IgAV, formerly known as Henoch-Schonlein purpura) is the most common cause of systemic vasculitis in chil …
ISTH guidelines for treatment of thrombotic thrombocytopenic purpura.
Zheng XL, Vesely SK, Cataland SR, Coppo P, Geldziler B, Iorio A, Matsumoto M, Mustafa RA, Pai M, Rock G, Russell L, Tarawneh R, Valdes J, Peyvandi F. Zheng XL, et al. J Thromb Haemost. 2020 Oct;18(10):2496-2502. doi: 10.1111/jth.15010. Epub 2020 Sep 11. J Thromb Haemost. 2020. PMID: 32914526 Free PMC article.
BACKGROUND: Despite advances in treatment options for thrombotic thrombocytopenic purpura (TTP), there are still limited high quality data to inform clinicians regarding its appropriate treatment. ...For first acute episode and relapses of iTTP, the panel made a strong rec …
BACKGROUND: Despite advances in treatment options for thrombotic thrombocytopenic purpura (TTP), there are still limited high quality …
Purpura fulminans: recognition, diagnosis and management.
Chalmers E, Cooper P, Forman K, Grimley C, Khair K, Minford A, Morgan M, Mumford AD. Chalmers E, et al. Arch Dis Child. 2011 Nov;96(11):1066-71. doi: 10.1136/adc.2010.199919. Epub 2011 Jan 12. Arch Dis Child. 2011. PMID: 21233082 Review.
Purpura fulminans (PF) is a haematological emergency in which there is skin necrosis and disseminated intravascular coagulation. ...
Purpura fulminans (PF) is a haematological emergency in which there is skin necrosis and disseminated intravascular coagulation. ...
Haemolytic uremic syndrome: diagnosis and management.
Sheerin NS, Glover E. Sheerin NS, et al. F1000Res. 2019 Sep 25;8:F1000 Faculty Rev-1690. doi: 10.12688/f1000research.19957.1. eCollection 2019. F1000Res. 2019. PMID: 31598213 Free PMC article. Review.
Traditionally, TMAs have been classified as either thrombotic thrombocytopenic purpura (TTP) or haemolytic uremic syndrome (HUS) based on the clinical presentation, with neurological involvement predominating in the former and acute kidney injury in the latter. ...
Traditionally, TMAs have been classified as either thrombotic thrombocytopenic purpura (TTP) or haemolytic uremic syndrome (HUS) base …
Advances in the management of TTP.
Subhan M, Scully M. Subhan M, et al. Blood Rev. 2022 Sep;55:100945. doi: 10.1016/j.blre.2022.100945. Epub 2022 Feb 17. Blood Rev. 2022. PMID: 35216839 Review.
Thrombotic thrombocytopenic purpura is an acute life-threatening disorder, associated with a mortality of 90% if unrecognised and untreated. ...High dose steroids are used from presentation and anti-CD20 monoclonal antibody therapy, specifically rituximab, is initia …
Thrombotic thrombocytopenic purpura is an acute life-threatening disorder, associated with a mortality of 90% if unrecognised and unt …
Thrombocytopenia: Evaluation and Management.
Gauer RL, Whitaker DJ. Gauer RL, et al. Am Fam Physician. 2022 Sep;106(3):288-298. Am Fam Physician. 2022. PMID: 36126009
Patients with platelet counts between 20 and 50 103 per muL may have mild skin manifestations such as petechiae, purpura, or ecchymosis. Patients with platelet counts of less than 10 103 per muL have a high risk of serious bleeding. ...
Patients with platelet counts between 20 and 50 103 per muL may have mild skin manifestations such as petechiae, purpura, or ecchymos …
1,104 results